Stonegate Capital Partners updates coverage on Burcon Nutrascience Corporation, highlighting their achievement in scaling up commercial production of pea protein isolate, strategic partnerships, and new product launches. The company aims for profitability in FY26 with a valuation range of $23.85 to $29.78.